Citation Impact
Citing Papers
Platinum-RNA Modifications Following Drug Treatment in S. cerevisiae Identified by Click Chemistry and Enzymatic Mapping
2014
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo
2007
The role of the insulin-like growth factor-1 system in breast cancer
2015
Astrocytes: biology and pathology
2009 Standout
From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice
2007
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
2010
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
2018
Functional responses and in vivo anti-tumour activity of h7C10: A humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors
2007
Dysregulation of growth factor signaling in human hepatocellular carcinoma
2006
IGF-I mediated survival pathways in normal and malignant cells
2006
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
2014 StandoutNobel
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
2006
Insulin-Like Growth Factor (IGF) family and prostate cancer
2006
Akt-regulated pathways in prostate cancer
2005
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function
2007
Epidemiology of Prostate Cancer
2019 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy
2013
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors
2007
Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer
2005
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Three generations of α,γ-diaminobutyric acid modified poly(propyleneimine) dendrimers and their cisplatin-type platinum complexes
2006
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
2006
Pancreatic Cancer
2010 Standout
TFOS DEWS II Sex, Gender, and Hormones Report
2017
Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road Ahead
2009
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer
2008
Natural products in drug discovery
2008 Standout
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
2008
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
2011 Standout
Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer
2014
Development of a Scalable Synthesis to VEGFR Inhibitor AG-28262
2006
Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma
2008
Diabetes and Cancer
2010 Standout
Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor
2007
Diverse Applications of Electronic-Nose Technologies in Agriculture and Forestry
2013
The Effects of Insulin-like Growth Factor 1 and Growth Hormone on Human Meibomian Gland Epithelial Cells
2014
Combination therapy in combating cancer
2017 Standout
Electronic noses for food quality: A review
2014 Standout
Targeting Signal Transduction Pathways in Colorectal Cancer—More Than Skin Deep
2005
Functional Oligothiophenes: Molecular Design for Multidimensional Nanoarchitectures and Their Applications
2009 Standout
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
New iminophosphorane-mediated synthesis of thieno[3′,2′:4,5]thieno[3,2-d]pyrimidin-4(3H)-ones and 5H-2,3-dithia-5,7-diaza-cyclopenta[c,d]indenes
2008
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Disrupting insulin-like growth factor signaling as a potential cancer therapy
2007
Microwave-based synthesis of novel thienopyrimidine bioisosteres of gefitinib
2007
Surgery for weight loss in adults
2014 Standout
The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance
2008
Enzyme Degradable Hyperbranched Polyphosphoester Micellar Nanomedicines for NIR Imaging-Guided Chemo-Photothermal Therapy of Drug-Resistant Cancers
2018
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
2007
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
2007
Gene Expression Profiling in the Discovery, Optimization and Development of Novel Drugs: One Universal Screening Platform
2006
Works of Catherine Soderstrom being referenced
Use of an electronic tongue to analyze mold growth in liquid media
2003
Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity
2003
Ultra-Sensitive Measurement of IL-17A and IL-17F in Psoriasis Patient Serum and Skin
2017
A practical guide for the stabilization of acylghrelin in human blood collections
2010
Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871
2005